Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022
Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, Vera Rauschenberger, Michael Eisenmann, Julia Reusch, Alexander Gabel, Sven Flemming, Oliver Andrés, Nils Petri, Max S. Topp, Michael Papsdorf, Miriam McDonogh, Raoul Verma-Führing, Agmal Scherzad, Daniel Zeller, Hartmut Böhm, Anja Gesierich, Anna Katharina Seitz, Michael Kiderlen, Micha Gawlik, Regina Taurines, Thomas Wurmb, Ralf‐Ingo Ernestus, Johannes Förster, Dirk Weismann, Benedikt Weißbrich, Lars Dölken, Johannes G. Liese, Lars Kaderali, Oliver Kurzai, Ulrich Vogel, Manuel Krone
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirusReverse transcription polymerase chain reactionPoint of careCoronavirus disease 2019 (COVID-19)VirusPoint-of-care testing2019-20 coronavirus outbreakDiagnostic testAntigenPolymerase chain reactionMedicineReal-time polymerase chain reactionReverse transcriptaseBiologyImmunologyInfectious disease (medical specialty)Veterinary medicineGenePathologyDiseaseGeneticsMessenger RNAOutbreakSARS-CoV-2 detection and testingBiosensors and Analytical DetectionMolecular Biology Techniques and Applications